HNRNPA0 and neoplasm: Differential interaction of phosphorylated hnRNP A0 with mRNAs in cancer versus non‐tumorous cells underscores its potential as a target for tumor treatment, highlighting the critical impact of phosphorylation on its tumor‐specific functions.[111] Moreover, Akt kinase inhibition disrupts hnRNP L phosphorylation, diminishing its binding to HPV16 mRNAs, and subsequently enhances HPV16 late gene expression through altered RNA processing.